Discontinued — last reported Q3 '24
Europe — Revenue
Edwards Lifesciences Europe — Revenue decreased by 4.7% to $319.80M in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 0.8%, from $322.30M to $319.80M. Over 2 years (FY 2021 to FY 2023), Europe — Revenue shows an upward trend with a 5.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing demand for structural heart technologies and successful market expansion in Europe, while a decrease may signal competitive pressure, pricing challenges, or macroeconomic headwinds in the region.
Detailed definition
This metric represents the total net sales generated from the sale of medical devices and structural heart technologies...
Peer comparison
Comparable to regional net sales figures reported by other global medical device manufacturers, typically benchmarked against regional market growth rates for cardiovascular products.
ew_segment_europe_revenue_from_contract_with_customer_excluding_assessed_taxHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $309.80M | $291.10M | $309.40M | $311.10M | $302.80M | $270.10M | $290.80M | $331.10M | $336.20M | $322.30M | $344.90M | $367.80M | $335.60M | $319.80M |
| QoQ Change | — | -6.0% | +6.3% | +0.5% | -2.7% | -10.8% | +7.7% | +13.9% | +1.5% | -4.1% | +7.0% | +6.6% | -8.8% | -4.7% |
| YoY Change | — | — | — | — | -2.3% | -7.2% | -6.0% | +6.4% | +11.0% | +19.3% | +18.6% | +11.1% | -0.2% | -0.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's europe — revenue?
- Edwards Lifesciences (EW) reported europe — revenue of $319.80M in Q3 2024.
- How has Edwards Lifesciences's europe — revenue changed year-over-year?
- Edwards Lifesciences's europe — revenue decreased by 0.8% year-over-year, from $322.30M to $319.80M.
- What is the long-term trend for Edwards Lifesciences's europe — revenue?
- Over 2 years (2021 to 2023), Edwards Lifesciences's europe — revenue has grown at a 5.9% compound annual growth rate (CAGR), from $1.19B to $1.33B.
- What does europe — revenue mean?
- The total net revenue earned from selling products to customers located in the European region.